Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation.
Autonomix Medical has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Autonomix Medical's investors include Synergy Partners International.
Autonomix Medical is headquartered in Excelsior, United States.
Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation.
Autonomix Medical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Autonomix Medical — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/autonomix-medical. Accessed August 18, 2026.
VCBacked. (2025). Autonomix Medical — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/autonomix-medical
{{cite web |title=Autonomix Medical — Funding & Investors |url=https://www.vcbacked.co/company/autonomix-medical |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated